Ready to unlock the potential of technology in drug safety? Look no further! Join us at IQVIA Innovate 2023, the Global Drug Safety Conference that promises to elevate your organization's processes and data with cutting-edge technology. Here's why you can't afford to miss it: • Engage in thought-provoking roundtable sessions on industry hot topics. • Network with your peers and connect with like-minded professionals. • Explore the world of pharmacovigilance with timely sessions on Generative AI, technology-driven efficiency, Real-World Evidence, and more. Don't miss out on this opportunity to stay at the forefront of innovation in drug safety. Register now and be part of the transformation! 🌐 #IQVIAInnovate2023 #DrugSafety https://bit.ly/3QFky1f
IQVIA Safety & Regulatory Compliance’s Post
More Relevant Posts
-
Are you ready to navigate the complexities of post-approval drug lifecycle management? Discover the strategies for success in our latest white paper, “Effective Strategies for Post-Approval Lifecycle Management and Local Pharmacovigilance,” authored by IQVIA’s experts. Discover how to overcome common regulatory challenges, implement effective regulatory strategies, and leverage partnerships for post-approval success. Gain insights into the role of Local Qualified Persons for Pharmacovigilance (LQPPVs) and how they are integral to maintaining compliance and fostering innovation across global markets. Unlock the full potential of your post-approval processes by reading our comprehensive guide: https://bit.ly/3B06euZ #Pharmacovigilance #RegulatoryAffairs #DrugLifecycleManagement #LQPPV #LCM
-
-
Did you know that a proactive approach to artwork creation in preclinical stages helps avoid common mistakes, maximize drug potential, and bring treatments to market faster? From competitor label analysis and aspirational label claims to TPP guidance and early regulatory engagement, IQVIA’s Rama Mohan Rao Chikkam discusses how drug developers can make more informed labelling decisions. Read his insights in full. https://bit.ly/4dYu20N #drugdevelopment #labeling
-
-
Curious about which companies excel in delivering exceptional value, performance, and quality? Frost & Sullivan's Customer Value Leadership Award celebrates those that go beyond good service to create significant value for their customers. Discover why IQVIA’s SmartSolve® eQMS stands out as a proud recipient— read the press release now: https://bit.ly/3XmLpBl
-
Mark your calendars! Jason Berning, the Associate Business Development Director for Regulatory Technology Solutions at IQVIA, will be speaking at the 6th Annual European Medical Device & Diagnostic Post-market Surveillance & Vigilance Conference. With two insightful presentations lined up, this event is a golden opportunity to discover effective solutions for your most significant challenges. Don’t wait, secure your spot today! https://lnkd.in/eCt7hCBr
-
There's still time to register. Don't miss learning how Medical Information is evolving beyond chatbots: https://lnkd.in/deH6VXVc
Are you leveraging Healthcare-grade AI™ technology to optimize Medical Information? Register now for our upcoming webinar and gain crucial insights into the top challenges for MI departments, effective strategies to overcome them, and best practices for integrating advanced technologies into MI services. Learn from our MI experts, Simon Johns and Louise Molloy: https://bit.ly/3MrAmlw #MI #MedicalInformation #MedicalAffairs #GenAI
-
-
With the introduction of the EU’s AI Act, it’s crucial for QARA departments to guide their companies in adhering to new standards. Everything you need to help you future-proof your QARA practices is here, including an on-demand webinar: https://lnkd.in/e3jbBm8W #QARA
-
If you’re heading to the upcoming RAPS Convergence in California, come along to IQVIA Booth #503 to meet our experts! Discover the latest industry innovations from your flexible, efficient, and tech-enabled regulatory partner. See you there! https://bit.ly/47DRX3z #RegulatoryCompliance
-
-
Are you ready for the upcoming FDA R3 regulatory changes? If you need to stay on track with regulatory authority compliance requirements—from EDQM doses and formulations to WHO MPID mapping—IQVIA offers rapid-response solutions for complete compliance. Discover how we can help your PV organization stay focused on what matters. Contact us now! https://bit.ly/3zb0Ep7
-
-
The life sciences industry is on the cusp of transformative regulatory changes, and while the uncertainty is challenging, the latest developments offer real opportunities for drug developers. In this article, IQVIA’s Keith McDonald considers how 2024’s regulatory shifts are paving the way for innovation and acceleration. Read his insights in full. https://bit.ly/3zhcoGz #regulatory #drugdevelopment
-
-
Are you ready to join IQVIA at RAPS Convergence in Long Beach, CA, September 17-19? Our regulatory affairs experts are excited to meet and discuss your regulatory needs and help you navigate the ever-evolving regulatory landscape. Come and visit Regulatory Affairs and Drug Development Solutions (RADDS) at IQVIA’s booth #530 and meet Parker Holmes, Carla Nelson, and Tom Stergar, II. They are eager to set up a meeting to discuss how our end-to-end regulatory solutions can support you along the regulatory continuum. Don’t miss attending and connecting with IQVIA’s regulatory experts. Learn more: https://bit.ly/3TmR35q #RAPS #RAPSConvergence #RegulatoryAffairs
-
